Skip to main content

Table 5 Clinical characteristics of G1P[8], G2P[4], and G1P[4]P[8] in 167 children more than 3 months of age

From: Changing distribution of age, clinical severity, and genotypes of rotavirus gastroenteritis in hospitalized children after the introduction of vaccination: a single center study in Seoul between 2011 and 2014

Clinical G1P[8] G2P[4] G1P[4]P[8] Pvalue* P value** P value***
(n = 24) (n = 33) (n = 22)
Ages, median months 24.0 [14.5–31.5] 42.0 [25.0–62.5 45.0 [29.5–79.0] 0.005 0.003 0.122
Complete vaccination, n (%) 2 (8.3) 3 (9.1) 1 (4.5) 0.921 0.344 0.529
Modified Vesikari score, median 11 [10–12] 12 [11–13] 12 [10–14] 0.077 0.230 0.889
Modified Vesikari score ≥ 11, n (%) 17 (70.8) 27 (81.8) 16 (72.7) 0.333 0.888 0.428
Vomiting duration, h, n (%) 0 5 (20.8) 0 2 (9.1) 0.018 0.165 0.535
1–24 17 (70.8) 27 (81.8) 16 (72.7)    
25–48 2 (8.3) 5 (15.2) 3 (13.6)    
≥ 49 0 1 (3.0) 1 (4.5)    
Maximum number of episodes per 24-h, n (%) 0 5 (20.8) 0 2 (9.1) 0.006 0.091 0.428
1 5 (20.8) 3 (9.1) 2 (9.1)    
2–4 9 (37.5) 16 (48.5) 10 (45.5)    
≥ 5 5 (20.8) 14 (42.4) 8 (36.4)    
Diarrhea duration, h, n (%) 0 2 (8.3) 6 (18.2) 3 (13.6) 0.180 0.973 0.283
1–96 21 (87.5) 27 (81.8) 17 (77.3)    
97–120 1 (4.2) 0 1 (4.5)    
≥ 121 0 0 1 (4.5)    
Maximum number of episodes per 24-h, n (%), 0 2 (8.3) 6 (18.2) 3 (13.6) 0.161 0.454 0.571
1–3 7 (29.2) 13 (39.4) 8 (36.4)    
4–5 6 (25.0) 5 (15.2) 4 (18.2)    
≥ 6 9 (37.5) 9 (27.3) 7 (31.8)    
Fever, °C, n (%) ≤ 37.0 4 (16.7 %) 3 (9.1 %) 1 (4.5 %) 0.229 0.220 0.978
37.1–38.4 12 (50 %) 14 (42.4 %) 10 (45.5 %)    
38.5–38.9 4 (16.7 %) 8 (24.2 %) 7 (31.8 %)    
≥ 39.0 4 (16.7 %) 8 (24.2 %) 4 (18.2 %)    
Visit to emergency department, n (%) 15 (62.5) 17 (51.5) 10 (45.5) 0.413 0.252 0.663
Seizure, n (%) 1 (4.2) 1 (3.0) 0 0.156 0.338 0.414
Total CO2, median mmol/L 16.0 [14.0–18.0] 17.0 [14.5–18.5] 17.5 [14.8–19.0] 0.769 0.244 0.337
  1. *G2P[4] compared to G1P[8]
  2. **G1P[4]P[8] compared to G1P[8]
  3. ***G2P[4] compared to G1P[4]P[8]